EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Circulating microRNAs as Early Biomarkers of Colon Cancer: A Nested Case-Control Study Within a Prospective Cohort

Lisa Padroni iD, Giorgia Marmiroli, Laura De Marco iD, Valentina Fiano, Lucia Dansero iD, Saverio Caini iD, Giovanna Masala iD, Luca Manfredi iD, Lorenzo Milani iD, Fulvio Ricceri iD, Carlotta Sacerdote

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167893 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lisa Padroni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), University of Turin, 10043 Turin,…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Biomarkers, Tumor, Circulating MicroRNA, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Governo Italiano, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating microRNAs (miRNAs) have emerged as non-invasive biomarkers that may be associated with cancer risk, but their role in the development of colon cancer is still not well understood. We conducted a nested case-control study within the EPIC-Italy cohort to investigate the association between pre-diagnostic serum levels of eight candidate miRNAs (Let7, Mir21, Mir155, Mir181, Mir222, Mir145, Mir92, and Mir20) and subsequent colon cancer occurrence. A total of 104 incident colon cancer cases were matched to 104 controls by center, sex, age, recruitment date, and vital status. miRNA expression was quantified using RT-qPCR and normalized to Mir484. Logistic regression models were applied to estimate odds ratios, 95% confidence intervals, and p-values, adjusting for age at recruitment, smoking status, body mass index, physical activity, adherence to a Mediterranean diet, and socioeconomic position. Elevated expression of Let7 (OR = 0.91; 95% CI: 0.84–1.00; p = 0.04) was associated with slightly lower odds of colon cancer in unadjusted models. Mir21 and Mir222 showed borderline associations (p = 0.07 and p = 0.09, respectively), but these did not remain significant after Bonferroni correction. This result was consistent in the multivariate logistic model: higher levels of Let7 (OR = 0.91; 95% CI: 0.82–1.00; p = 0.06) and Mir222 (OR = 0.75; 95% CI: 0.57–1.00; p = 0.05) are suggestive of an association with lower odds of colon cancer. Our findings highlight the challenges of using circulating miRNAs as very early biomarkers, particularly when samples are collected nearly a decade before diagnosis. Future studies with larger sample sizes, serial blood collections, and integration with inflammatory and immune markers will be crucial to clarify the temporal dynamics of circulating miRNA alterations and their potential role in risk-adapted screening strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsBiomarkers, TumorCirculating MicroRNAMicroRNAsHumansMaleFemaleCase-Control StudiesMiddle AgedAgedProspective StudiesRisk Factors

Stichwörter der Autor:innen

colon cancermicroRNAnested case-control study

Substanzen

Biomarkers, TumorCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), University of Turin, 10043 Turin, Italy.
  • Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Unit of Cancer Epidemiology, Città Della Salute e Della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.
  • Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.
  • Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.
  • Department of Health Sciences, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy.

ORCID-Profile: Lisa Padroni, Laura De Marco, Lucia Dansero, Saverio Caini, Giovanna Masala, Luca Manfredi, Lorenzo Milani, Fulvio Ricceri

Förderung

  • Governo Italiano
  • Italian Ministry of Health

Zitieren

APA

Padroni, L., Marmiroli, G., De Marco, L., Fiano, V., Dansero, L., Caini, S., Masala, G., Manfredi, L., Milani, L., Ricceri, F., & Sacerdote, C. (2025). Circulating microRNAs as Early Biomarkers of Colon Cancer: A Nested Case-Control Study Within a Prospective Cohort. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167893

Vancouver

Padroni L, Marmiroli G, De Marco L, Fiano V, Dansero L, Caini S, et al. Circulating microRNAs as Early Biomarkers of Colon Cancer: A Nested Case-Control Study Within a Prospective Cohort. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167893

BibTeX
@article{Padroni2025,
  author = {Padroni, Lisa and Marmiroli, Giorgia and De Marco, Laura and Fiano, Valentina and Dansero, Lucia and Caini, Saverio and Masala, Giovanna and Manfredi, Luca and Milani, Lorenzo and Ricceri, Fulvio and Sacerdote, Carlotta},
  title = {Circulating microRNAs as Early Biomarkers of Colon Cancer: A Nested Case-Control Study Within a Prospective Cohort},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167893}
}
Kostenlos starten →